Showing results (11-20 of 147) with videos related to
Sort By:
Pageof 15
CNS Drugs|July 4, 2018
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An OverviewFloriana De Angelis, Domenico Plantone, Jeremy ChatawayLondon Journal of Primary Care|May 8, 2015
Service development or research: make sure you know which game you are playingJeremy Chataway, Ayesha Ali, Norma O' FlynnThe Lancet. Neurology|March 17, 2015
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesDaniel Ontaneda, Robert J Fox, Jeremy ChatawayPharmaceuticals (Basel, Switzerland)|September 28, 2023
The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with CorticosteroidsMartin Rakusa, Jeremy Chataway, Todd A HardyEuropean Journal of Haematology|December 14, 2005
Steroid-responsive functional B12 deficiency in association with transcobalamin II polymorphism 776C --> GDaniel P Gale, Jeremy F Cobbold, Jeremy ChatawayMultiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2022
The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosisSarah Alexander, Marie Braisher, Carmen Tur, et al.Handbook of Clinical Neurology|September 25, 2024
Adult inflammatory leukoencephalopathiesThomas Williams, Nevin John, Anisha Doshi, et al.Journal of Neurology|July 17, 2020
Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot studyVivien Li, Jalesh N Panicker, Collette Haslam, et al.JAMA Neurology|May 5, 2020
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in EnglandRaffaele Palladino, Ruth Ann Marrie, Azeem Majeed, et al.Neurology|September 2, 2021
Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort StudyRaffaele Palladino, Jeremy Chataway, Azeem Majeed, et al.Pageof 15